Editorial Board

Pharmacognosy Research is guided by an independent international board. All submissions are handled by a section editor with no conflict of interest and reviewed under a double-anonymized policy.

Editor-in-Chief

Dr. Srisailam Keshetti

University of Toronto, Canada

Pharmacognosy Research provides peer-reviewed original research articles from the field of Natural Products. The journal serves an international audience of scientists and researchers in a variety of research and academia by quickly disseminating research findings related to Medicinal Plants and Natural Products. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submissions of original contributions in all areas of pharmacognosy are welcome. Editorial correspondence and appeals may be addressed to the Editor-in-Chief through the submission system.

Senior Editorial Team

3 members

Sets editorial policy, arbitrates appeals and oversees the double-anonymized review process.

  • Deputy Editor

    Anika Nakamura

    MIT, United States

  • Deputy Editor

    Katarina Lindqvist

    Universidade de São Paulo, Brazil

  • Ethics & Integrity Editor

    Wei Duarte

    University of Cape Town, South Africa

    Research integrity, retractions

Associate Editors

0 members

One handling editor per section, responsible for reviewer selection and decisions.

    Advisory Board

      Serving on the board

      Associate editors serve renewable three-year terms. Nominations, including self- nominations from active reviewers of PR, are reviewed twice a year by the senior editorial team.